Novozymes A/S (CPH:NSIS.B)
387.70
+4.40 (1.15%)
May 22, 2026, 4:59 PM CET
Novozymes Market Cap
Novozymes has a market cap or net worth of 180.63 billion as of May 22, 2026. Its market cap has decreased by -10.53% in one year.
Market Cap
180.63B
Enterprise Value
202.20B
Revenue
31.39B
Ranking
n/a
PE Ratio
40.57
Stock Price
387.70
Market Cap Chart
Since February 26, 2001, Novozymes's market cap has increased from 14.15B to 180.63B, an increase of 1,176.73%. That is a compound annual growth rate of 10.61%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 22, 2026 | 180.63B | -4.87% |
| Dec 30, 2025 | 189.89B | 0.24% |
| Dec 30, 2024 | 189.43B | 84.24% |
| Dec 29, 2023 | 102.82B | 5.66% |
| Dec 30, 2022 | 97.30B | -34.61% |
| Dec 30, 2021 | 148.80B | 51.92% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| DSV A/S | 365.18B |
| Danske Bank | 269.77B |
| A.P. Møller - Mærsk | 225.09B |
| Ørsted | 220.82B |
| Vestas Wind Systems | 196.36B |
| Carlsberg | 120.95B |
| Genmab | 105.72B |
| Tryg A/S | 93.36B |